期刊文献+

CT冠状动脉成像评价冠状动脉慢性完全闭塞病变的价值 被引量:5

Value of coronary CT angiography to the evaluation of coronary chronic total occlusion
原文传递
导出
摘要 目的探讨CT冠状动脉成像评价冠状动脉慢性完全闭塞(chronic total occlusion,CTO)病变的价值。方法回顾性分析30例经冠状动脉造影确诊为冠状动脉CTO病变患者的冠状动脉CT血管成像(coronary computed tomography angiography,CCTA)影像资料,分析冠状动脉CTO病变的CCTA特征。结果 30例患者CCTA显示43个冠状动脉闭塞节段,CCTA诊断CTO病变的敏感度为86.04%,特异度为98.94%;冠状动脉CTO病变53.49%位于右冠状动脉,72.09%合并钙化。结论CCTA诊断冠状动脉CTO病变具有较高敏感度及特异度,可显示冠状动脉CTO病变特征。 Objective To evaluate the value of coronary computed tomography angiography (CCTA) to the evaluation of coronary chronic total occlusion (CTO). Methods The CCTA imaging data were retrospectively analyzed in 30 patients with coronary angiographically confirmed CTO, and the CCTA characteristics of coronary CTO were studied. Results Thirty patients were found 43 coronary artery occlusion segments, the sensitivity of CCTA for the diagnosis of CTO was 86.04%, and the specificity was 98.94%. OCT was mostly located in the right coronary artery (53.49%), commonly complicated with calcification (72.09%). Conclusion CCTA has a high sensitivity and specifieity for the diagnosis of CTO, and can show the characteristics of CTO.
作者 邢艳 刘倩 党军 肖虎 刘文亚 XING Yan;LIU Qian;DANG Jun;XIAO Hu;LIU Wen-ya(Imaging Center,the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830011,China)
出处 《中华实用诊断与治疗杂志》 2018年第8期800-802,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 新疆维吾尔自治区自然科学基金(2015211C074)
关键词 冠状动脉 慢性完全性闭塞 CT血管成像 Coronary artery chronic total occlusion computed tomography angiography
  • 相关文献

参考文献8

二级参考文献51

  • 1蔡军,张龙江,卢光明,黄伟,周长圣,赵艳娥,孙志远,梁泉.双源CT冠状动脉成像检查异常冠状动脉起源的意义[J].医学研究生学报,2011,24(8):835-839. 被引量:7
  • 2乔树宾,侯青,徐波,陈珏,刘海波,杨跃进,吴永健,袁晋青,吴元,戴军,尤士杰,马卫华,张沛,高展,窦克非,邱洪,慕朝伟,陈纪林,高润霖.药物洗脱支架对完全闭塞性病变介入治疗预后影响的评估[J].中华心血管病杂志,2006,34(11):979-982. 被引量:4
  • 3朱汉东,朱国英,苏晞,宋丹,陈国洪,彭剑.冠状动脉慢性完全闭塞的临床预测因素分析[J].中国医师进修杂志(内科版),2007,30(7):20-22. 被引量:1
  • 4张同,王巍,申宝忠.64排螺旋CT对冠心病的诊断价值[J].实用放射学杂志,2007,23(8):1040-1042. 被引量:11
  • 5de Felice F, Fiorilli R, Parma A, et al. 3-year clinical outcome of patients with chronic total occlusion treated with drug-eluting stents. JACC Cardiovasc Interv, 2009,2(12) : 1260-1265. 被引量:1
  • 6Salinas P, j imenez-Valero S, Moreno R, et al , Update in pharmacological management of coronary no-reflow phenomenon [J]. Cardiovasc Hematol Agents Med Chem,2012, 10(3): 256- 264. 被引量:1
  • 7Chan W, Stub D, Clark D J, et al , Usefulness of transient and persistent no-reflow to predict adverse clinical outcomes following percutaneous coronary intervention[J]. Am J Cardiol, 2012,109(4) :478-485. 被引量:1
  • 8O'Gara P T, Kushner F G, Ascheim D D, et al . 2013 ACCF/ AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines[J]. Circulation, 2013,127 (4) : e362-e425. 被引量:1
  • 9Jeong Y H, Kim W J, Park D W, et al . Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction[J]. Int J Cardiol , 2010,141(2):175-181. 被引量:1
  • 10Akpek M, Kaya M G, Uyarel H, et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI[J]. Atherosclerosis, 2011,219(1) : 334- 341. 被引量:1

共引文献86

同被引文献51

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部